Published in Gut on May 01, 1990
Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest (1994) 3.40
Plasma ghrelin following cure of Helicobacter pylori. Gut (2003) 2.20
Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut (1993) 1.85
Evidence of clonal variants of Helicobacter pylori in three generations of a duodenal ulcer disease family. Gut (1992) 1.24
Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease. Gut (1993) 1.24
Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. Gut (1997) 1.22
Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut (1995) 1.20
Importance of gastrin in the pathogenesis and treatment of gastric tumors. World J Gastroenterol (2009) 1.12
Role of bacteria in oncogenesis. Clin Microbiol Rev (2010) 1.05
Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17. Gut (1993) 1.04
Effect of Helicobacter pylori infection on 24 hour intragastric acidity in patients with gastritis and duodenal ulcer. Gut (1992) 1.00
Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence. Br J Cancer (2002) 0.98
Optimizing acid suppression for treatment of acid-related diseases. Dig Dis Sci (1995) 0.96
Role of ammonia in the pathogenesis of the gastritis, hypergastrinaemia, and hyperpepsinogenaemia I caused by Helicobacter pylori infection. Gut (1992) 0.90
Effects of acid suppression on microbial flora of upper gut. Dig Dis Sci (1995) 0.90
Correlation between gastrointestinal symptoms and gastric leptin and ghrelin expression in patients with gastritis. Dig Dis Sci (2007) 0.88
Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection. Dig Dis Sci (2002) 0.88
Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum. Gut (1996) 0.86
Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease? Gut (1998) 0.83
Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation. Gut (1999) 0.83
Helicobacter pylori infection, gastrin and cyclooxygenase-2 in gastric carcinogenesis. World J Gastroenterol (2014) 0.83
Hypergastrinemia. Gastroenterol Rep (Oxf) (2015) 0.82
Does Helicobacter pylori infection contribute to gastroesophageal reflux disease? Yale J Biol Med (1999) 0.82
Altered gastrin regulation in mice infected with Helicobacter felis. Dig Dis Sci (2000) 0.81
Helicobacter pylori upregulates prion protein expression in gastric mucosa: a possible link to prion disease. World J Gastroenterol (2005) 0.81
Significance of an exaggerated meal-stimulated gastrin response in pathogenesis of Helicobacter pylori-negative duodenal ulcer. Dig Dis Sci (2003) 0.81
Helicobacter pylori augments the acid inhibitory effect of omeprazole on parietal cells and gastric H(+)/K(+)-ATPase. Gut (2001) 0.81
Role of gastrin-peptides in Barrett's and colorectal carcinogenesis. World J Gastroenterol (2012) 0.81
Helicobacter pylori infection and fasting plasma glucose concentration. J Clin Pathol (2001) 0.80
Human gastrin mRNA expression up-regulated by Helicobacter pylori CagA through MEK/ERK and JAK2-signaling pathways in gastric cancer cells. Gastric Cancer (2011) 0.80
Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens. Gut (1993) 0.80
Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis. Dig Dis Sci (1995) 0.80
Endoscopic diagnosis and management of type I neuroendocrine tumors. World J Gastrointest Endosc (2015) 0.79
Effects of Helicobacter pylori on histamine and carbachol stimulated acid secretion by human parietal cells. Gut (1994) 0.79
Helicobacter pylori infection and severity of reflux-induced esophageal disease in a cohort of patients with columnar-lined esophagus. Dig Dis Sci (2007) 0.78
Helicobacter pylori and peptic ulcer disease. West J Med (1993) 0.78
Helicobacter pylori, HIV and Gastric Hypochlorhydria in the Malawian Population. PLoS One (2015) 0.77
The relationship between helicobacter pylori infection and gastro-esophageal reflux disease. N Am J Med Sci (2011) 0.77
Helicobacter suis affects the health and function of porcine gastric parietal cells. Vet Res (2016) 0.77
Helicobacter pylori, ghrelin, and obesity. Gut (2004) 0.76
Helicobacter pylori and gastric acid: an intimate and reciprocal relationship. Therap Adv Gastroenterol (2016) 0.75
Assay of gastrin and somatostatin in gastric antrum tissues of children with chronic gastritis and duodenal ulcer. World J Gastroenterol (2006) 0.75
Gastrin and Gastric Cancer. Cell Mol Gastroenterol Hepatol (2017) 0.75
Gastric histamine concentration and IgE in Helicobacter pylori infection. J Clin Pathol (1992) 0.75
A morphometric study of antral G-cell density in a sample of adult general population: comparison of three different methods and correlation with patient demography, helicobacter pylori infection, histomorphology and circulating gastrin levels. Int J Clin Exp Pathol (2008) 0.75
A Five-Year-Old Boy with Marked Hypergastrinemia Associated with H. pylori Infection. Case Rep Gastroenterol (2010) 0.75
Helicobacter pylori-induced gastritis may contribute to occurrence of postprandial symptomatic hypoglycemia. Dig Dis Sci (1999) 0.75
Effect of enprostil on omeprazole-induced hypergastrinemia and inhibition of gastric acid secretion in peptic ulcer patients. Dig Dis Sci (1997) 0.75
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet (1984) 32.58
Campylobacter like organisms on the gastric mucosa: culture, histological, and serological studies. J Clin Pathol (1984) 10.23
Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol (1986) 9.90
Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet (1989) 9.76
Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol (1987) 7.09
Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet (1989) 6.58
The clinical significance of Campylobacter pylori. Ann Intern Med (1988) 5.08
Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study. Lancet (1987) 4.32
A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology (1989) 3.66
Gastritis and Campylobacter pylori in healthy, asymptomatic volunteers. Arch Intern Med (1988) 3.03
Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels. Lancet (1989) 2.14
Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol (1988) 1.97
The relationship between basal and maximum acid output in normal subjects and patients with duodenal ulcer. Clin Sci (1963) 1.58
Total 24-hour gastric acid secretion in patients with duodenal ulcer. Comparison with normal subjects and effects of cimetidine and parietal cell vagotomy. Gastroenterology (1986) 1.48
Twenty-four-hour intragastric acidity and plasma gastrin concentration in healthy subjects and patients with duodenal or gastric ulcer, or pernicious anaemia. Aliment Pharmacol Ther (1987) 1.35
Campylobacter pylori: fact or fancy? Gastroenterology (1988) 1.29
Acid secretion and serum gastrin levels in individuals with Campylobacter pylori. Gastroenterology (1988) 1.28
Pattern of 24 hour intragastric acidity in active duodenal ulcer disease and in healthy controls. Gut (1988) 1.22
Persistence of Campylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis. Dig Dis Sci (1987) 1.18
Mucosa-related bacteria in the stomach. Lancet (1984) 1.09
Campylobacter-like organisms and gastritis: histopathology, bile reflux, and gastric fluid composition. Scand J Gastroenterol (1987) 1.07
Is peptic ulceration a hormonal disease? Lancet (1977) 1.04
The effects of famotidine, 40 mg at night, on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects. Scand J Gastroenterol (1988) 1.01
Maximum acid output and position of peptic ulcers. Lancet (1976) 0.82
Gastric acid secretion and Campylobacter pylori. Gastroenterology (1988) 0.82
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67
Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans. Infect Immun (1975) 14.65
Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor. Infect Immun (1977) 10.84
Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 9.99
Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1995) 9.77
New surface-associated heat-labile colonization factor antigen (CFA/II) produced by enterotoxigenic Escherichia coli of serogroups O6 and O8. Infect Immun (1978) 8.52
Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli. Infect Immun (1973) 8.47
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol (1992) 8.35
Is measles vaccination a risk factor for inflammatory bowel disease? Lancet (1995) 6.75
Stimulation of adenyl cyclase by Escherichia coli enterotoxin. Nat New Biol (1972) 6.65
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med (1992) 6.64
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther (2002) 6.17
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother (1996) 6.01
Norwalk virus genome cloning and characterization. Science (1990) 5.83
Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea. Infect Immun (1978) 5.71
Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet (1989) 5.70
Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab (1982) 5.60
Travelers' diarrhea and toxigenic Escherichia coli. N Engl J Med (1975) 5.20
Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet (1987) 5.02
Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med Microbiol Immunol (1976) 4.95
Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol (1981) 4.87
Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology (1991) 4.86
Polymyxin B-Induced Release of Low-Molecular-Weight, Heat-Labile Enterotoxin from Escherichia coli. Infect Immun (1974) 4.79
Hemagglutination patterns of enterotoxigenic and enteropathogenic Escherichia coli determined with human, bovine, chicken, and guinea pig erythrocytes in the presence and absence of mannose. Infect Immun (1979) 4.60
Three characteristics associated with enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 4.42
In vitro transcription and translation of simian rotavirus SA11 gene products. J Virol (1980) 4.40
A simple clinical colitis activity index. Gut (1998) 4.35
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA (1999) 4.25
BVA policy on farm animal welfare. Vet Rec (1991) 4.25
Purification and characterization of the CFA/I antigen of enterotoxigenic Escherichia coli. Infect Immun (1979) 4.24
Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol (1999) 4.13
Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology (1998) 4.12
Identification of enterotoxigenic Escherichia coli and serum antitoxin activity by the vascular permeability factor assay. Infect Immun (1973) 4.07
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer (2008) 3.87
Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet (1992) 3.85
Infantile diarrhea produced by heat-stable enterotoxigenic Escherichia coli. N Engl J Med (1976) 3.82
Detection of Norwalk virus in stool by polymerase chain reaction. J Clin Microbiol (1992) 3.82
Effect of cimetidine on 24-hour intragastric acidity in normal subjects. Gut (1976) 3.75
A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology (1989) 3.66
A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci U S A (2000) 3.66
Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol (1996) 3.57
Direct serological assay for the heat-labile enterotoxin of Escherichia coli, using passive immune hemolysis. Infect Immun (1977) 3.57
In vitro production of choleragen and vascular permeability factor by Vibrio cholerae. J Bacteriol (1968) 3.52
Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet (2000) 3.42
Diagnostic criteria for schwannomatosis. Neurology (2005) 3.41
The course of patients after variceal hemorrhage. Gastroenterology (1981) 3.33
Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J Bacteriol (1996) 3.32
Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol (1998) 3.31
Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol (1996) 3.20
Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut (1984) 3.18
N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen. Infect Immun (1988) 3.16
Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet (1992) 3.13
Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group. Lancet (1991) 3.09
Patterns of loss of enterotoxigenicity by Escherichia coli isolated from adults with diarrhea: suggestive evidence for an interrelationship with serotype. Infect Immun (1977) 3.04
Hemagglutination typing of Escherichia coli: definition of seven hemagglutination types. J Clin Microbiol (1980) 3.03
Identification of a cis-acting replication element within the poliovirus coding region. J Virol (2000) 3.03
Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology (1992) 3.02
Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome. Lancet (1976) 3.00
Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol (1993) 2.96
Ultrastructural localization of rotavirus antigens using colloidal gold. Virus Res (1984) 2.95
Comparative susceptibility of latin american and united states students to enteric pathogens. N Engl J Med (1976) 2.94
Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology (1992) 2.83
Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections. J Clin Microbiol (1981) 2.82
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet (2008) 2.81
Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without the colonization factor antigen. Infect Immun (1978) 2.78
24-hour control of intragastric acidity by cimetidine in duodenal-ulcer patients. Lancet (1975) 2.67
Identification, synthesis, and modifications of simian rotavirus SA11 polypeptides in infected cells. J Virol (1982) 2.67
A plaque assay for the simian rotavirus SAII. J Gen Virol (1979) 2.65
Role of Escherichia coli colonisation factor antigen in acute diarrhoea. Lancet (1978) 2.65
Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ (1996) 2.64
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci (1991) 2.63
A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother (1997) 2.63